Cargando…

Keeping track of all ongoing colorectal cancer trials using a mobile application: Usability and satisfaction results of the Dutch Colorectal Cancer Group Trials application

BACKGROUND AND AIM: Both the number and complexity of medical trials are increasing vastly. To facilitate easy access to concise trial information, a freely available mobile application including all ongoing clinical trials of the Dutch Colorectal Cancer Group (DCCG) was developed. The aim of this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huiskens, Joost, Gałek-Aldridge, Michael S., Bakker, Jean-Michel, Olthof, Pim B., van Gulik, Thomas M., Punt, Cornelis J. A., van Oijen, Martijn G. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Whioce Publishing Pte. Ltd. 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412602/ https://www.ncbi.nlm.nih.gov/pubmed/30873493

Ejemplares similares

From registration to publication: A study on Dutch academic randomized controlled trials
por: Huiskens, Joost, et al.
Publicado: (2020)

Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG)
por: Huiskens, Joost, et al.
Publicado: (2015)

Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
por: Bolhuis, Karen, et al.
Publicado: (2021)

Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group
por: Bond, Marinde J. G., et al.
Publicado: (2023)

ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery—Portal Vein Embolization
por: Olthof, Pim B., et al.
Publicado: (2020)

UGT1A1(*)28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
por: Kweekel, D M, et al.
Publicado: (2008)

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials
por: Goey, Kaitlyn K H, et al.
Publicado: (2017)

The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival
por: Höppener, Diederik J., et al.
Publicado: (2019)

Biomedical nanomaterials for immunological applications: ongoing research and clinical trials
por: Lenders, Vincent, et al.
Publicado: (2020)

The use of a NHS-PEG coated, collagen-based sealant in a patient undergoing Associating Liver Partition and Portal vein Ligation for Staged hepatectomy (ALPPS)
por: Olthof, Pim B., et al.
Publicado: (2018)

The CAIRO4 study: the role of surgery of the primary tumour with few or absent symptoms in patients with synchronous unresectable metastases of colorectal cancer – a randomized phase III study of the Dutch Colorectal Cancer Group (DCCG)
por: ’t Lam - Boer, Jorine, et al.
Publicado: (2014)

The Dutch multicenter experience of the Endo-Sponge treatment for anastomotic leakage after colorectal surgery
por: van Koperen, P. J., et al.
Publicado: (2008)

Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
por: Hospers, Geke A., et al.
Publicado: (2007)

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases
por: Bolhuis, Karen, et al.
Publicado: (2021)

Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial
por: Belkouz, Ali, et al.
Publicado: (2020)

KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases
por: van 't Erve, Iris, et al.
Publicado: (2021)

Institutional work to maintain, repair, and improve the regulatory regime: How actors respond to external challenges in the public supervision of ongoing clinical trials in the Netherlands
por: van Oijen, Jacqueline C. F., et al.
Publicado: (2020)

Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
por: Ruers, Theo, et al.
Publicado: (2017)

Definition of colorectal anastomotic leakage: A consensus survey among Dutch and Chinese colorectal surgeons
por: van Rooijen, Stefanus J, et al.
Publicado: (2017)

Usable Mobile App for Community Education on Colorectal Cancer: Development Process and Usability Study
por: Mohamad Marzuki, Muhamad Fadhil, et al.
Publicado: (2019)

Level of Digitization in Dutch Hospitals and the Lengths of Stay of Patients with Colorectal Cancer
por: van Poelgeest, Rube, et al.
Publicado: (2017)

The Dutch COVID-19 Contact Tracing App (the CoronaMelder): Usability Study
por: Bente, Britt Elise, et al.
Publicado: (2021)

Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model
por: Franken, Mira D., et al.
Publicado: (2020)

Conversion of a colorectal cancer guideline into clinical decision trees with assessment of validity
por: Keikes, Lotte, et al.
Publicado: (2021)

Bounding the per-protocol effect in randomized trials: an application to colorectal cancer screening
por: Swanson, Sonja A., et al.
Publicado: (2015)

ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer
por: Trumpi, K., et al.
Publicado: (2015)

Conceptualizing Usability for the eHealth Context: Content Analysis of Usability Problems of eHealth Applications
por: Broekhuis, Marijke, et al.
Publicado: (2021)

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014
por: Punt, Cornelis JA, et al.
Publicado: (2015)

Ongoing EEG Phase as a Trial-by-Trial Predictor of Perceptual and Attentional Variability
por: VanRullen, R., et al.
Publicado: (2011)

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
por: Ros, Javier, et al.
Publicado: (2023)

The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment
por: Wesdorp, Nina J., et al.
Publicado: (2021)

Ongoing trials in low-grade lymphoma
por: Burchardt, Alexander
Publicado: (2011)

Overview of Ongoing Clinical Trials on Radioembolization
por: Fabritius, Matthias P., et al.
Publicado: (2022)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

Technical efficiency evaluation of colorectal cancer care for older patients in Dutch hospitals
por: Heil, Thea C., et al.
Publicado: (2021)

GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group
por: Kweekel, D M, et al.
Publicado: (2008)

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial
por: Kurk, Sophie A., et al.
Publicado: (2019)

Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients
por: Kurk, Sophie A., et al.
Publicado: (2018)

Minimally Invasive Liver Surgery: A Snapshot from a Major Dutch HPB and Transplant Center
por: Marino, Rebecca, et al.
Publicado: (2022)

The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS
por: Daradics, Noemi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_72fpbjqlrtnmvmm2b45kribilr